Background: -ionone is a terminal cyclic analog of
beta-carotenoids widely found in plants. In recent years, accumulating evidence
has shown that -ionone exerts antitumor effects on various malignant
tumors. However, limited studies have revealed the role of -ionone in
regulating the epithelial-mesenchymal transition (EMT) of prostate cancer (PCa)
cells. This study aimed to investigate the effect of -ionone on the EMT
process of PCa, focusing on Wnt/-catenin signaling pathway.
Methods: After exposure to -ionone, cell viability was
determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) assay and the Brdu proliferation assay. The Transwell and wounding healing
were used to investigate the migration and invasion abilities of PCa cells.
Expression of proteins involved in the EMT process (E-cadherin, N-cadherin,
vimentin) and proteins in the Wnt/-catenin pathway (-catenin,
GSK3-, and p-GSK3-) were explored by western blotting. The
effects of -ionone on -catenin degradation were explored by
cycloheximide tracking assay and in vitro ubiquitination assay. Nude
mouse xenograft model was served as the model system in vivo.
Results: The migration, invasion, and EMT process of PCa Human PC-3 prostate adenocarcinoma cells (PC3) and Human 22RV1 prostate adenocarcinoma cells (22RV1)
cells were significantly inhibited after -ionone treatment. In addition,
-ionone also inhibited the growth and EMT process of subcutaneous
xenograft tumors in nude mice. The study also found that -catenin, which
promotes EMT, was downregulated after -ionone treatment. Further
mechanistic studies revealed that -ionone inhibited the
Wnt/-catenin pathway by accelerating the ubiquitination and degradation
of -catenin in PCa, thus inhibiting the downstream migration, invasion,
and EMT processes. Conclusions: These findings demonstrate that
-ionone may be a potential natural compound targeting the
Wnt/-catenin pathway for the treatment of PCa.